- Non-Small Cell Lung Cancer Treatment - NCI
Non-small cell lung cancer (NSCLC) treatment options include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy Laser therapy, photodynamic therapy, cryosurgery, and electrocautery may be used Learn more about NSCLC in this expert-reviewed summary
- Update 2025: Management of Non‑Small-Cell Lung Cancer - PMC
Since 2024, the non–small-cell lung cancer (NSCLC) landscape has undergone a transformative shift, driven by 11 FDA approvals Recent advances in molecular profiling, targeted therapies, and immunotherapies have revolutionized NSCLC management, ushering in an era of personalized treatment with improved patient outcomes
- Treatment of Lung Cancer | Lung Cancer | CDC
Treatment options Lung cancer is treated in several ways, depending on the type of lung cancer and how far it has spread People with non-small cell lung cancer can be treated with surgery, chemotherapy, radiation therapy, targeted therapy, or a combination of these treatments
- Treatment Options for Non-Small Cell Lung Cancer (NSCLC)
Treatments for NSCLC usually depend on the stage of your cancer and may include surgery, chemotherapy, and radiation therapy Learn more
- New NCCN Guidelines Add Treatment Options for NSCLC
New NSCLC guideline updates outline expanded perioperative immunotherapy, adjuvant targeted therapy, and consolidation strategies, supported by phase III data and informed by molecular testing
- Non-Small Cell Lung Cancer (NSCLC) Treatment: Your Options
Treatment for non-small cell lung cancer (NSCLC) depends on the stage and can include chemotherapy, surgery, radiation, or targeted therapy
- FAQs About Non-Small Cell Lung Cancer
Treatment options for non-small cell lung cancer could include surgery, chemotherapy, immunotherapy, or even a clinical trial
- Non-Small Cell Lung Cancer (NSCLC) Treatment Management
Surgery is the treatment of choice for patients with non–small cell lung cancer (NSCLC) stages I through IIIA In addition, patients with resected lung cancer have a high risk of relapse and so are treated with adjuvant chemotherapy Patients with stage IIIB and IV NSCLC are usually offered chemotherapy with the option of surgery
|